DOI:
10.1055/s-00000009
American Journal of Perinatology
LinksClose Window
References
Zhong Y, Lee K, He JC.
SIRT1 is a potential drug target for treatment of diabetic kidney disease.
Front Endocrinol (Lausanne) 2018;
9: 624
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.